메뉴 건너뛰기




Volumn 15, Issue , 2015, Pages 37-41

In silico models of M. Tuberculosis infection provide a route to new therapies

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

EID: 84899664431     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2014.02.006     Document Type: Review
Times cited : (12)

References (38)
  • 2
    • 77956216718 scopus 로고    scopus 로고
    • Understanding latent tuberculosis: A moving target
    • P.L. Lin, and J.L. Flynn Understanding latent tuberculosis: a moving target J. Immunol. 185 2010 15 22
    • (2010) J. Immunol. , vol.185 , pp. 15-22
    • Lin, P.L.1    Flynn, J.L.2
  • 3
    • 84877267006 scopus 로고    scopus 로고
    • Advances in the development of new tuberculosis drugs and treatment regimens
    • A. Zumla, and et al. Advances in the development of new tuberculosis drugs and treatment regimens Nat. Rev. Drug Discov. 12 2013 388 404
    • (2013) Nat. Rev. Drug Discov. , vol.12 , pp. 388-404
    • Zumla, A.1
  • 4
    • 79955111092 scopus 로고    scopus 로고
    • Macrophages and control of granulomatous inflammation in tuberculosis
    • J.L. Flynn, and et al. Macrophages and control of granulomatous inflammation in tuberculosis Mucosal Immunol. 4 2011 271 278
    • (2011) Mucosal Immunol. , vol.4 , pp. 271-278
    • Flynn, J.L.1
  • 5
    • 84883668448 scopus 로고    scopus 로고
    • Modeling the Mycobacterium tuberculosis granuloma - The critical battlefield in host immunity and disease
    • E. Guirado, and L.S. Schlesinger Modeling the Mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease Front. Immunol. 4 2013 98
    • (2013) Front. Immunol. , vol.4 , pp. 98
    • Guirado, E.1    Schlesinger, L.S.2
  • 6
    • 84891853921 scopus 로고    scopus 로고
    • Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
    • P.L. Lin, and et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing Nat. Med. 20 2014 75 79
    • (2014) Nat. Med. , vol.20 , pp. 75-79
    • Lin, P.L.1
  • 7
    • 6344281115 scopus 로고    scopus 로고
    • Identifying control mechanisms of granuloma formation during M. Tuberculosis infection using an agent-based model
    • J.L. Segovia-Juarez, and et al. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model J. Theor. Biol. 231 2004 357 376
    • (2004) J. Theor. Biol. , vol.231 , pp. 357-376
    • Segovia-Juarez, J.L.1
  • 8
    • 65449166781 scopus 로고    scopus 로고
    • Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection
    • J.C. Ray, and et al. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection J. Immunol. 182 2009 3706 3717
    • (2009) J. Immunol. , vol.182 , pp. 3706-3717
    • Ray, J.C.1
  • 9
    • 79953194081 scopus 로고    scopus 로고
    • Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation
    • M. Fallahi-Sichani, and et al. Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation J. Immunol. 186 2011 3472 3483
    • (2011) J. Immunol. , vol.186 , pp. 3472-3483
    • Fallahi-Sichani, M.1
  • 10
    • 84880273351 scopus 로고    scopus 로고
    • Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection
    • N.A. Cilfone, and et al. Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection PLoS ONE 8 2013 e68680
    • (2013) PLoS ONE , vol.8 , pp. e68680
    • Cilfone, N.A.1
  • 11
    • 77955478490 scopus 로고    scopus 로고
    • Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma
    • M. Fallahi-Sichani, and et al. Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma PLoS Comput. Biol. 6 2010 e1000778
    • (2010) PLoS Comput. Biol. , vol.6 , pp. e1000778
    • Fallahi-Sichani, M.1
  • 12
    • 84859377308 scopus 로고    scopus 로고
    • Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability
    • M. Fallahi-Sichani, and et al. Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability J. Immunol. 188 2012 3169 3178
    • (2012) J. Immunol. , vol.188 , pp. 3169-3178
    • Fallahi-Sichani, M.1
  • 13
    • 84866354551 scopus 로고    scopus 로고
    • NF-kappaB signaling dynamics play a key role in infection control in tuberculosis
    • M. Fallahi-Sichani, and et al. NF-kappaB signaling dynamics play a key role in infection control in tuberculosis Front. Physiol. 3 2012 170
    • (2012) Front. Physiol. , vol.3 , pp. 170
    • Fallahi-Sichani, M.1
  • 14
    • 33745622432 scopus 로고    scopus 로고
    • Early events in Mycobacterium tuberculosis infection in cynomolgus macaques
    • P.L. Lin, and et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques Infect. Immun. 74 2006 3790 3803
    • (2006) Infect. Immun. , vol.74 , pp. 3790-3803
    • Lin, P.L.1
  • 15
    • 80053931194 scopus 로고    scopus 로고
    • A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages
    • G. Magombedze, and N. Mulder A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages J. Theor. Biol. 292 2012 44 59
    • (2012) J. Theor. Biol. , vol.292 , pp. 44-59
    • Magombedze, G.1    Mulder, N.2
  • 16
    • 84857474188 scopus 로고    scopus 로고
    • Two-drug antimicrobial chemotherapy: A mathematical model and experiments with Mycobacterium marinum
    • P. Ankomah, and B.R. Levin Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum PLoS Pathog. 8 2012 e1002487
    • (2012) PLoS Pathog. , vol.8 , pp. e1002487
    • Ankomah, P.1    Levin, B.R.2
  • 17
    • 34548861262 scopus 로고    scopus 로고
    • GSMN-TB: A web-based genome-scale network model of Mycobacterium tuberculosis metabolism
    • D.J. Beste, and et al. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism Genome Biol. 8 2007 R89
    • (2007) Genome Biol. , vol.8 , pp. R89
    • Beste, D.J.1
  • 18
    • 84883173541 scopus 로고    scopus 로고
    • (13)C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis
    • D.J. Beste, and et al. (13)C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis Chem. Biol. 20 2013 1012 1021
    • (2013) Chem. Biol. , vol.20 , pp. 1012-1021
    • Beste, D.J.1
  • 19
    • 79960933284 scopus 로고    scopus 로고
    • (1)(3)C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation
    • D.J. Beste, and et al. (1)(3)C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation PLoS Pathog. 7 2011 e1002091
    • (2011) PLoS Pathog. , vol.7 , pp. e1002091
    • Beste, D.J.1
  • 20
    • 78649617204 scopus 로고    scopus 로고
    • Carbon flux rerouting during Mycobacterium tuberculosis growth arrest
    • L. Shi, and et al. Carbon flux rerouting during Mycobacterium tuberculosis growth arrest Mol. Microbiol. 78 2010 1199 1215
    • (2010) Mol. Microbiol. , vol.78 , pp. 1199-1215
    • Shi, L.1
  • 21
    • 34447317247 scopus 로고    scopus 로고
    • Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets
    • N. Jamshidi, and B.O. Palsson Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets BMC Syst. Biol. 1 2007 26
    • (2007) BMC Syst. Biol. , vol.1 , pp. 26
    • Jamshidi, N.1    Palsson, B.O.2
  • 22
    • 84866925914 scopus 로고    scopus 로고
    • Modeling phenotypic metabolic adaptations of Mycobacterium tuberculosis H37Rv under hypoxia
    • X. Fang, and et al. Modeling phenotypic metabolic adaptations of Mycobacterium tuberculosis H37Rv under hypoxia PLoS Comput. Biol. 8 2012 e1002688
    • (2012) PLoS Comput. Biol. , vol.8 , pp. e1002688
    • Fang, X.1
  • 23
    • 70449513046 scopus 로고    scopus 로고
    • A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis
    • X. Fang, and et al. A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis BMC Syst. Biol. 3 2009 92
    • (2009) BMC Syst. Biol. , vol.3 , pp. 92
    • Fang, X.1
  • 24
    • 79953209270 scopus 로고    scopus 로고
    • Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid
    • A.G. Bhat, and et al. Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid Syst. Synth. Biol. 4 2010 299 309
    • (2010) Syst. Synth. Biol. , vol.4 , pp. 299-309
    • Bhat, A.G.1
  • 25
    • 84876933802 scopus 로고    scopus 로고
    • Shifting from the single to the multitarget paradigm in drug discovery
    • J.L. Medina-Franco, and et al. Shifting from the single to the multitarget paradigm in drug discovery Drug Discovery Today 18 2013 495 501
    • (2013) Drug Discovery Today , vol.18 , pp. 495-501
    • Medina-Franco, J.L.1
  • 26
    • 84924184136 scopus 로고    scopus 로고
    • A systems biology approach for understanding granuloma formation and function in tuberculosis
    • J. McFadden, D.J.V. Beste, A.M. Kierzek, Springer
    • M. Fallahi-Sichani, and et al. A systems biology approach for understanding granuloma formation and function in tuberculosis J. McFadden, D.J.V. Beste, A.M. Kierzek, Systems biology of tuberculosis 2013 Springer
    • (2013) Systems Biology of Tuberculosis
    • Fallahi-Sichani, M.1
  • 27
    • 45449094504 scopus 로고    scopus 로고
    • A methodology for performing global uncertainty and sensitivity analysis in systems biology
    • S. Marino, and et al. A methodology for performing global uncertainty and sensitivity analysis in systems biology J. Theor. Biol. 254 2008 178 196
    • (2008) J. Theor. Biol. , vol.254 , pp. 178-196
    • Marino, S.1
  • 28
    • 35748953415 scopus 로고    scopus 로고
    • Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue
    • S. Marino, and et al. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue PLoS Comput. Biol. 3 2007 1909 1924
    • (2007) PLoS Comput. Biol. , vol.3 , pp. 1909-1924
    • Marino, S.1
  • 29
    • 33646025858 scopus 로고    scopus 로고
    • Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection
    • D. Sud, and et al. Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection J. Immunol. 176 2006 4296 4314
    • (2006) J. Immunol. , vol.176 , pp. 4296-4314
    • Sud, D.1
  • 30
    • 84455169868 scopus 로고    scopus 로고
    • Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions
    • M.C. Kjellsson, and et al. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions Antimicrob. Agents Chemother. 56 2012 446 457
    • (2012) Antimicrob. Agents Chemother. , vol.56 , pp. 446-457
    • Kjellsson, M.C.1
  • 31
    • 79954595692 scopus 로고    scopus 로고
    • High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions
    • B. Prideaux, and et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions Anal. Chem. 83 2011 2112 2118
    • (2011) Anal. Chem. , vol.83 , pp. 2112-2118
    • Prideaux, B.1
  • 32
    • 84881114100 scopus 로고    scopus 로고
    • Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model
    • R.S. Wallis, and et al. Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model PLoS ONE 8 2013 e71116
    • (2013) PLoS ONE , vol.8 , pp. e71116
    • Wallis, R.S.1
  • 33
    • 67649991190 scopus 로고    scopus 로고
    • Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs
    • S. Goutelle, and et al. Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs Antimicrob. Agents Chemother. 53 2009 2974 2981
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 2974-2981
    • Goutelle, S.1
  • 34
    • 33845580084 scopus 로고    scopus 로고
    • Mathematical modeling of chemotherapy of human TB infection
    • G. Magombedze, and et al. Mathematical modeling of chemotherapy of human TB infection J. Biol. Syst. 14 2006 509 553
    • (2006) J. Biol. Syst. , vol.14 , pp. 509-553
    • Magombedze, G.1
  • 35
    • 44449128516 scopus 로고    scopus 로고
    • Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption
    • J.J. Wilkins, and et al. Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption Antimicrob. Agents Chemother. 52 2008 2138 2148
    • (2008) Antimicrob. Agents Chemother. , vol.52 , pp. 2138-2148
    • Wilkins, J.J.1
  • 36
    • 71849100552 scopus 로고    scopus 로고
    • Advances in immunotherapy for tuberculosis treatment
    • ix
    • G.J. Churchyard, and et al. Advances in immunotherapy for tuberculosis treatment Clin. Chest Med. 30 2009 769 782 ix
    • (2009) Clin. Chest Med. , vol.30 , pp. 769-782
    • Churchyard, G.J.1
  • 37
    • 34447256528 scopus 로고    scopus 로고
    • Immunotherapeutics for tuberculosis in experimental animals: Is there a common pathway activated by effective protocols?
    • G.A. Rook, and et al. Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols? J. Infect. Dis. 196 2007 191 198
    • (2007) J. Infect. Dis. , vol.196 , pp. 191-198
    • Rook, G.A.1
  • 38
    • 21844433456 scopus 로고    scopus 로고
    • Reconsidering adjuvant immunotherapy for tuberculosis
    • R.S. Wallis Reconsidering adjuvant immunotherapy for tuberculosis Clin. Infect. Dis. 41 2005 201 208
    • (2005) Clin. Infect. Dis. , vol.41 , pp. 201-208
    • Wallis, R.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.